Felodipine Tablet, Film Coated, Extended Release
Product Images NDC 65862-673

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Felodipine (NDC 65862-673). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel – 2.5 mg (100 Tablet Bottle) (Felodipine Fig1)

Package Label-principal Display Panel – 2.5 mg (100 Tablet Bottle) (Felodipine Fig1)
NDC 65862-673-01 is a prescription medication called Felodipine, which comes in a pack of 100 tablet form. Each of the film-coated extended-release tablets contains Felodipine USP 2.5 mg. The usual adult dosage is stated in accompanying prescribing information. The tablets need to be stored at a temperature between 20°C to 25°C (68°F to 77°F) and must be protected from light. It is necessary to keep the container tightly closed, out of children's reach, and in a tight, light-resistant container defined in the USP, utilizing two child-resistant closures. The drug cannot be crushed or chewed and should be swallowed as a whole. The product is distributed by Aurobindo Pharma, USA, Inc., and it is made in India. The text contains information regarding the medication's dosage, administration, storage, and distribution details.*
FDA Label Image

Package Label-principal Display Panel – 2.5 mg Blister Carton (10 X 10 Unit-dose) (Felodipine Fig2)

FDA Label Image

Package Label-principal Display Panel – 5 mg (100 Tablet Bottle) (Felodipine Fig3)

Package Label-principal Display Panel – 5 mg (100 Tablet Bottle) (Felodipine Fig3)
This is a description of Felodipine extended-release tablets. The tablets are prescription-only and are produced by Aurobindo Pharma USA, Inc. The tablets come in a container that is resistant to acid and light. The recommended adult dosage is not mentioned in this text, but can be found in the prescribing information that accompanies the medication. These tablets contain 5 mg of the active ingredient Felodipine USP. The instructions on the container indicate that the tablets should be kept at a controlled room temperature, protected from light, and out of the reach of children. The tablets should be swallowed whole and not crushed or chewed. The drug is made in India and has a unique identifying code.*
FDA Label Image

Package Label-principal Display Panel – 10 mg (100 Tablet Bottle) (Felodipine Fig4)

Package Label-principal Display Panel – 10 mg (100 Tablet Bottle) (Felodipine Fig4)
This is a medication with the brand name Felodipine. It is an extended-release tablet containing 10mg of Felodipine USP intended for adult use only. The medicine's storage temperature should be controlled at around 20°C to 25°C and kept away from light. Also, the tablets should not be crushed or chewed, but swallowed whole. Aurobindo Pharma USA, Inc is responsible for distribution, and the medication is manufactured in India. The code "TS/DRUGS/22/2009" is embossed for identification purposes.*
FDA Label Image

Package Label-principal Display Panel – 10 mg Blister Carton (10 X 10 Unit-dose) (Felodipine Fig5)

Package Label-principal Display Panel – 10 mg Blister Carton (10 X 10 Unit-dose) (Felodipine Fig5)
Felodipine Extended-Release tablets contain a prescription medication used to treat high blood pressure. Each coated unit-dose tablet contains 10 mg of the medicine. The package contains 10x 10 tablets. The medication must be used according to the accompanying prescription. The tablets should be swallowed whole or can be chewed. The drug is manufactured by Aurobindo Pharma USA.*
FDA Label Image

Chemical Structure (Felodipine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.